There are individual differences in the life expectancy of patients with early cirrhosis. Most patients have long-term stable disease after active treatment, which has little impact on life expectancy, while patients who are not actively treated can progress to decompensated cirrhosis, with a 5-year survival rate of about 50%. A variety of diseases can lead to cirrhosis, such as long-term alcohol abuse, hepatitis B, drug-related hepatitis, hepatitis C, autoimmune liver disease, and cholestatic liver disease. The early stage of cirrhosis, also known as compensated cirrhosis, is characterized by symptoms such as nausea, weakness, indigestion, and discomfort in the liver area. If treated aggressively to get rid of the causes, such as quitting alcohol and antiviral treatment for hepatitis B or C, the condition can be stabilized for a long time, or even reversing the cirrhosis, with little impact on the patient’s life expectancy. If the treatment is not active, it can progress to cirrhosis decompensated stage, and the patient’s life expectancy generally does not exceed 20 years. Patients in the early stage of cirrhosis should avoid drinking alcohol, exposure to hepatotoxic drugs, and pay attention to eating light, easily digestible and nutritious food.